Discover how high-throughput 3D screening of JIMT-1 breast cancer cells is revolutionizing our understanding of drug resistance and improving cancer treatment development.
Discover how lactate dehydrogenase (LDH) and lipid profiles serve as powerful biomarkers for predicting breast cancer aggression, metastasis, and survival outcomes.
Discover how EGFR and HER2 contribute equally to ERK activation in human mammary epithelial cells, revealing fundamental insights into breast cancer signaling.
Groundbreaking research reveals breast cancer cells can spread systemically far earlier than previously imagined—even before a visible tumor forms.
Exploring how biologic therapies are transforming phase II breast cancer clinical trials through precision medicine and innovative trial designs.
How randomized controlled trials transformed early breast cancer care from radical mastectomies to precision therapies with 90%+ survival rates
Exploring how open challenges and machine learning are transforming breast cancer prognosis through global collaboration and advanced data analysis.